| NDC Code | 59651-009-18 |
|---|
| Package Description | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-18) |
|---|
| Product NDC | 59651-009 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Ranolazine |
|---|
| Non-Proprietary Name | Ranolazine |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20221223 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA209081 |
|---|
| Manufacturer | Aurobindo Pharma Limited |
|---|
| Substance Name | RANOLAZINE |
|---|
| Strength | 500 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|